To date, no trials have studied the effects of such 5-HT3B receptor polymorphisms on responses to drugs in FGIDs. the metabolism and, hence, the pharmacokinetics of drugs used to treat FGIDs. Polymorphisms in the genes controlling proteins that are involved in the direct action of medications targeting the serotonergic, cannabinoid, […]